Holding(s) in Company

RNS Number : 9963O

Hikma Pharmaceuticals Plc

25 August 2017

 

TR-1: Standard form for notification of major holdings

LONDON, 25 August 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK) (LEI: 549300BNS685UXH4JI75), the fast-growing multinational pharmaceuticals group, announces as follows:

NOTIFICATION OF MAJOR HOLDINGS

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Hikma Pharmaceuticals PLC
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				YES
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Vanguard Health Care Fund
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		22 August 2017
6. Date on which issuer notified:		24 August 2017
7. Threshold(s) that is/are crossed or reached: vi, vii		3%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B0LCW083

7,186,729

7,186,729

7,284,981

7,284,981

3.03%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,284,981

3.03%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Vanguard Health Care Fund c/o The Vanguard Group, Inc. [e-mail]

15. Contact telephone number:

+001 [phone]

 

END

 

 

HOLUVOBRBVAWURR